IL97509A - תכשירים המורידים רמת ליפידים המכילים באמבוטרול - Google Patents

תכשירים המורידים רמת ליפידים המכילים באמבוטרול

Info

Publication number
IL97509A
IL97509A IL9750991A IL9750991A IL97509A IL 97509 A IL97509 A IL 97509A IL 9750991 A IL9750991 A IL 9750991A IL 9750991 A IL9750991 A IL 9750991A IL 97509 A IL97509 A IL 97509A
Authority
IL
Israel
Prior art keywords
bambuterol
lipid lowering
cholesterol
lipoprotein
hdl
Prior art date
Application number
IL9750991A
Other languages
English (en)
Other versions
IL97509A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL97509A0 publication Critical patent/IL97509A0/xx
Publication of IL97509A publication Critical patent/IL97509A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL9750991A 1990-03-16 1991-03-11 תכשירים המורידים רמת ליפידים המכילים באמבוטרול IL97509A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use

Publications (2)

Publication Number Publication Date
IL97509A0 IL97509A0 (en) 1992-06-21
IL97509A true IL97509A (he) 1995-12-31

Family

ID=20378886

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9750991A IL97509A (he) 1990-03-16 1991-03-11 תכשירים המורידים רמת ליפידים המכילים באמבוטרול

Country Status (28)

Country Link
US (2) US5837727A (he)
EP (1) EP0521967B1 (he)
JP (1) JP3081640B2 (he)
KR (1) KR100194995B1 (he)
AT (1) ATE138570T1 (he)
AU (1) AU653149B2 (he)
CA (1) CA2077762C (he)
CZ (1) CZ279308B6 (he)
DE (1) DE69119896T2 (he)
DK (1) DK0521967T3 (he)
EG (1) EG19645A (he)
ES (1) ES2087291T3 (he)
GR (1) GR3020700T3 (he)
HK (1) HK52197A (he)
HU (1) HU211998B (he)
IE (1) IE80668B1 (he)
IL (1) IL97509A (he)
LT (1) LT3734B (he)
LV (1) LV10917B (he)
MY (1) MY114218A (he)
NZ (1) NZ237279A (he)
PT (1) PT97052B (he)
RU (1) RU2093153C1 (he)
SE (1) SE9000948D0 (he)
SG (1) SG64895A1 (he)
SK (1) SK278815B6 (he)
WO (1) WO1991013615A1 (he)
ZA (1) ZA911452B (he)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US6459316B1 (en) * 2000-12-08 2002-10-01 Intel Corporation Flip flop circuit
US7067517B2 (en) * 2001-12-14 2006-06-27 Nero Nordisk A/S Use of compounds for decreasing activity of hormone-sensitive lipase
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
AU2002332488A1 (en) * 2002-08-08 2004-02-25 J. L. Cheng R-bambuterol, its preparation and therapeutic uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807B1 (en) * 1980-07-09 1984-05-30 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
US4472436A (en) * 1982-12-06 1984-09-18 Neo-Bionics, Inc. Increasing HDL-cholesterol levels with phenylethylamine derivatives
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use

Also Published As

Publication number Publication date
DE69119896T2 (de) 1996-10-10
JPH05504971A (ja) 1993-07-29
ATE138570T1 (de) 1996-06-15
SG64895A1 (en) 2000-01-25
LT3734B (en) 1996-02-26
AU653149B2 (en) 1994-09-22
PT97052B (pt) 1998-07-31
LV10917B (en) 1996-04-20
GR3020700T3 (en) 1996-10-31
WO1991013615A1 (en) 1991-09-19
HUT61461A (en) 1993-01-28
KR100194995B1 (ko) 1999-06-15
LV10917A (lv) 1995-12-20
NZ237279A (en) 1993-08-26
MY114218A (en) 2002-09-30
IL97509A0 (en) 1992-06-21
ZA911452B (en) 1991-11-27
EP0521967A1 (en) 1993-01-13
JP3081640B2 (ja) 2000-08-28
ES2087291T3 (es) 1996-07-16
EG19645A (en) 1995-09-30
DK0521967T3 (da) 1996-09-09
CA2077762C (en) 2001-06-12
CS9100681A2 (en) 1991-10-15
CZ279308B6 (cs) 1995-04-12
HU211998B (en) 1996-01-29
PT97052A (pt) 1991-10-31
SK278815B6 (sk) 1998-03-04
HU9202958D0 (en) 1992-12-28
LTIP1735A (en) 1995-07-25
HK52197A (en) 1997-05-02
IE80668B1 (en) 1998-11-18
DE69119896D1 (de) 1996-07-04
EP0521967B1 (en) 1996-05-29
RU2093153C1 (ru) 1997-10-20
US6034123A (en) 2000-03-07
AU7569191A (en) 1991-10-10
US5837727A (en) 1998-11-17
SE9000948D0 (sv) 1990-03-16
IE910862A1 (en) 1991-09-25
CA2077762A1 (en) 1991-09-17

Similar Documents

Publication Publication Date Title
EP1244460B1 (en) Use of dipyridinium compounds for treating a disease characterized by proliferating cells containing nitric oxide synthase
Morgan et al. A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients
US5593971A (en) Method for preventing onset of hypertension employing a cholesterol lowering drug
KR100200467B1 (ko) 콜레스테롤 저하제 및 ace 억제제로 이루어진 아테롬성 동맥경화증의 예방, 안정화 또는 경감용 조성물
MXPA03002964A (es) Composiciones y metodos para reducir lipoproteina a de plasma y factores de riesgo de enfermedades cardiovasculares.
JPH04235915A (ja) 血管拡張術後の再発狭窄症発作用医薬組成物
Ditschuneit et al. Comparison of different HMG-CoA reductase inhibitors
KR20010101790A (ko) (ｅ)-7-[4-(4-플루오로페닐)-6-이소프로필-2-[메틸(메틸술포닐)아미노]피리미딘-5-일](3ｒ,5ｓ)-3,5-디히드록시헵트-6-엔산 및 ｐ450 이소효소 3ａ4의 억제제, 유도제 또는기질을 함유하는 약물 조합물
Amin et al. RG 12561 (Dalvastatin): A novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent
EP0521967B1 (en) New use of bambuterol
CN105343024B (zh) 一种阿托伐他汀钙片剂及其制备方法
Banga et al. Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study
Wolffenbuttel et al. Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemia
HOLMES Drugs affecting lipid synthesis
EP0841913A1 (en) Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels
Krause et al. Gemfibrozil increases both apo AI and apo E concentrations: Comparison to other lipid regulators in cholesterol-fed rats
Guo et al. Inhibition of 11β-hydroxysteroid dehydrogenase by bioflavonoids and their interaction with furosemide and gossypol
Hasibeder et al. Clinical pharmacology of the hypocholesterolemic agent K 12.148 (lifibrol) in healthy volunteers
Amin et al. Lovastatin is hypertriglyceridemic in Syrian golden hamsters
US6630502B2 (en) Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
Naydenov Naydenov et al. Učinkovitost i sigurnost kombinacije atorvastatina/amlodipina u jednoj tableti kod bolesnika s arterijskom hipertenzijom i dislipidemijom
Matsubara et al. Angiotensin-converting enzyme inhibitors can potentiate ozone-induced airway hyperresponsiveness
Steyn The treatment of poisoning with alkylphosphate (organophosphate) insecticides
MXPA00003200A (en) Inhibtion of lipoprotein oxidation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
MM9K Patent not in force due to non-payment of renewal fees